Schedule 13G ownership disclosure

CONDUIT PHARMACEUTICALS INC

Common Stock, par value $0.0001 per share · CUSIP: 20678X205

Event date: 2025-03-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • A.G.P. / Alliance Global Partners, LLC

    Shares: 1,108,320.00 · Class: 9.8%

  • Alliance Global Holdings, Inc.

    Shares: 1,108,320.00 · Class: 9.8%

  • David Bocchi Family Trust

    Shares: 1,108,320.00 · Class: 9.8%

  • David A. Bocchi

    Shares: 1,108,320.00 · Class: 9.8%

  • Raffaele Gambardella

    Shares: 1,108,320.00 · Class: 9.8%

  • Phillip W. Michals

    Shares: 1,108,320.00 · Class: 9.8%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001641172-25-010946
Form type
SCHEDULE 13G
Filer
A.G.P. / ALLIANCE GLOBAL PARTNERS, LLC
CIK
CIK 318492
Filed
May 15, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub